According to research reviewed by Gram Research, serious side effects from low-dose methotrexate for rheumatoid arthritis are uncommon but can occur, particularly in older or frail patients. A 2026 case series of 18 patients found that 78% experienced blood problems, nausea, or skin reactions requiring hospital treatment, with 2 patients (11%) dying from severe infections. Most side effects responded to supportive care, but the study shows that careful monitoring is essential, especially for vulnerable populations.
Methotrexate is a common medication for rheumatoid arthritis that doctors consider relatively safe at low doses. However, a Gram Research analysis of 18 patients revealed that serious side effects can still occur, especially in older or weaker patients. The study found that these side effects affected multiple body systems—including blood problems, stomach issues, and skin reactions—but most could be managed with hospital care. Two patients died from severe infections, highlighting that while low-dose methotrexate is generally manageable, doctors need to watch carefully for warning signs in vulnerable patients.
Key Statistics
A 2026 case series of 18 rheumatoid arthritis patients found that 78% of those experiencing methotrexate side effects required rescue therapy with leucovorin calcium, an intravenous medication to help their bodies eliminate the drug.
Among 18 patients with methotrexate-related adverse reactions studied in 2026, 50% required blood transfusions due to dangerously low blood cell counts, and 11% died from severe infections.
A 2026 analysis of 18 methotrexate toxicity cases found that blood tests measuring methotrexate levels showed inconsistent relationships with side effects, meaning doctors cannot rely on lab values alone to predict who will have serious reactions.
In a 2026 case series of 18 patients with methotrexate complications, 44% received medications to boost white blood cell production, and 28% received sodium bicarbonate to help their bodies clear the drug faster.
The Quick Take
- What they studied: What happens when patients taking low-dose methotrexate for rheumatoid arthritis develop serious side effects, and how doctors can treat them.
- Who participated: 18 patients with rheumatoid arthritis (mostly women, average age 72) who experienced bad reactions to methotrexate between 2022 and 2025 at one hospital.
- Key finding: Most side effects involved blood problems, nausea, or skin issues and could be treated in the hospital. However, 2 out of 18 patients (11%) died from severe infections, showing that some people face life-threatening risks.
- What it means for you: If you take methotrexate for arthritis, know that serious side effects are possible but uncommon. Older adults and people in poor health face higher risks. Work closely with your doctor and report any unusual symptoms immediately.
The Research Details
Researchers looked back at medical records from 18 patients who had bad reactions to methotrexate at their hospital between March 2022 and August 2025. They excluded patients whose problems came from other drugs, infections, or vitamin deficiencies to focus only on methotrexate-related issues. The doctors described what happened to each patient—what symptoms they had, how they were treated, and what the outcome was—using simple counting and averages rather than complex statistics.
This type of study, called a case series, is useful for understanding rare or serious side effects that might not show up in larger studies. By carefully documenting what happened to these 18 patients, the researchers could identify patterns in how methotrexate causes problems and what treatments work best.
The study was limited to one hospital, so the findings may not apply everywhere. The small number of patients also means we can’t calculate exact risks or compare groups statistically.
Understanding what can go wrong with methotrexate helps doctors recognize warning signs early and treat problems faster. This research shows that serious side effects are possible even at ‘safe’ doses, which is important information for patients and doctors to discuss before starting the medication.
This study has important limitations: it’s small (only 18 patients), it only looked at people who had problems (not those who did fine), and it’s from one hospital. The researchers couldn’t prove that methotrexate caused the problems—they just documented what happened. There’s no comparison group of patients who didn’t have side effects. However, the detailed descriptions of each case provide valuable real-world information about how methotrexate toxicity appears and responds to treatment.
What the Results Show
Among the 18 patients studied, side effects affected multiple body systems. Blood-related problems were most common, including low red blood cell counts (anemia), low white blood cell counts, and bleeding. Stomach problems like nausea and vomiting also occurred frequently. Skin reactions included ulcers, redness, swelling, and pain.
Most patients needed hospital treatment to recover. About 78% received a rescue medication called leucovorin calcium through an IV to help their bodies eliminate the methotrexate. Half the patients needed blood transfusions because their blood counts dropped dangerously low. About 44% received a special medicine to boost white blood cell production, and 28% received sodium bicarbonate to make their urine less acidic, which helps the body clear methotrexate faster.
The good news: most patients recovered with these supportive treatments. The bad news: 2 patients (11%) died from severe infections that developed as complications. Both deaths occurred in elderly or frail patients, suggesting that age and overall health are important risk factors.
The study found that blood tests measuring methotrexate levels in the blood were not reliable for predicting who would have serious side effects. Some patients with high methotrexate levels had mild problems, while others with lower levels had severe reactions. This means doctors cannot simply check a blood test to know if a patient is in danger—they must watch for actual symptoms instead.
Methotrexate has been used for decades and is generally considered safe at low doses. This study confirms that serious side effects are uncommon but possible, especially in older patients. The types of side effects found here (blood problems, nausea, skin reactions) match what doctors have seen before, but this research provides detailed descriptions of how these problems develop and respond to treatment in real patients.
This study has several important limits: (1) Only 18 patients from one hospital—results may differ elsewhere; (2) Only looked at patients who had problems, not the thousands who take methotrexate safely; (3) Cannot prove methotrexate caused the problems, only that they happened while patients were taking it; (4) No comparison group to show how often these problems occur; (5) Older patients may have been overrepresented since the average age was 72. These limitations mean we cannot calculate exact risks or apply findings to all patients.
The Bottom Line
If you take methotrexate for rheumatoid arthritis: (1) Report any unusual symptoms to your doctor immediately—especially fever, unusual bruising, bleeding, severe nausea, or skin problems. (2) Keep all scheduled blood tests and doctor visits so your doctor can catch problems early. (3) Take folic acid supplements as prescribed, which may reduce side effects. (4) Discuss your age and overall health with your doctor—older or frail patients need closer monitoring. Confidence level: Moderate—based on real patient experiences but from a small study.
This research matters most for: (1) Older adults taking methotrexate (age 65+); (2) People with weak immune systems or other serious health conditions; (3) Doctors prescribing methotrexate who need to recognize serious side effects; (4) Patients considering methotrexate who want to understand potential risks. This does NOT mean methotrexate is unsafe—serious side effects are uncommon, but knowing the risks helps everyone stay safe.
Most side effects in this study developed while patients were actively taking methotrexate. Recovery with hospital treatment took days to weeks. If you notice symptoms, seek medical attention immediately rather than waiting—early treatment prevents serious complications.
Frequently Asked Questions
Is methotrexate safe for treating rheumatoid arthritis?
Methotrexate is generally considered safe at low doses and is widely used for arthritis. However, serious side effects can occur, especially in older or frail patients. A 2026 study of 18 patients found that 11% experienced life-threatening complications. Close monitoring with your doctor is essential.
What are the most common side effects of low-dose methotrexate?
According to a 2026 case series, the most common side effects involve blood problems (low counts), nausea and vomiting, and skin reactions like ulcers or redness. Most of these respond to hospital treatment, but they require medical attention and should not be ignored.
Can blood tests predict if methotrexate will cause serious side effects?
No. A 2026 study found that methotrexate blood levels showed inconsistent relationships with side effects—some patients with high levels had mild problems while others with lower levels had severe reactions. Doctors must watch for actual symptoms rather than relying on lab values alone.
Who is at highest risk for methotrexate side effects?
Older adults and people in poor overall health face higher risks. The 2026 case series found that both patients who died were elderly or frail. If you’re over 65 or have other serious health conditions, discuss your individual risk with your rheumatologist.
What should I do if I develop symptoms while taking methotrexate?
Report any unusual symptoms to your doctor immediately—especially fever, unusual bruising, bleeding, severe nausea, or skin problems. Don’t wait for your next scheduled appointment. Early treatment prevents serious complications. Keep all blood test appointments so your doctor can monitor for problems.
Want to Apply This Research?
- Log weekly methotrexate doses and any symptoms (nausea, unusual bruising, fever, skin changes, bleeding) to share with your doctor at appointments. Rate symptom severity 1-10 to track patterns.
- Set phone reminders for blood test appointments and folic acid supplements. Create a symptom checklist to review before each doctor visit so you don’t forget to mention problems.
- Track methotrexate doses, blood test dates and results, and any side effects monthly. Share this data with your rheumatologist to help them adjust your treatment if needed. Flag any new or worsening symptoms for immediate medical attention.
This article summarizes research about methotrexate side effects but is not medical advice. Methotrexate is an effective medication for many patients when properly monitored. Do not stop taking methotrexate or change your dose without talking to your doctor. If you experience symptoms like fever, unusual bruising, severe nausea, or difficulty breathing while taking methotrexate, seek immediate medical attention. This study was small (18 patients) and from one hospital, so individual risks may vary. Always discuss the benefits and risks of methotrexate with your rheumatologist based on your personal health situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.